- Home
- GLRE vs ANGO Comparison
GLRE vs ANGO Comparison
Compare GLRE & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLRE
- ANGO
- Stock Information
- Founded
- GLRE 2004
- ANGO 1988
- Country
- GLRE Cayman Islands
- ANGO United States
- Employees
- GLRE N/A
- ANGO N/A
- Industry
- GLRE Property-Casualty Insurers
- ANGO Medical/Dental Instruments
- Sector
- GLRE Finance
- ANGO Health Care
- Exchange
- GLRE Nasdaq
- ANGO Nasdaq
- Market Cap
- GLRE 466.5M
- ANGO 406.9M
- IPO Year
- GLRE 2007
- ANGO 2004
- Fundamental
- Price
- GLRE $14.19
- ANGO $9.37
- Analyst Decision
- GLRE
- ANGO Strong Buy
- Analyst Count
- GLRE 0
- ANGO 2
- Target Price
- GLRE N/A
- ANGO $15.50
- AVG Volume (30 Days)
- GLRE 166.6K
- ANGO 603.8K
- Earning Date
- GLRE 08-05-2025
- ANGO 07-15-2025
- Dividend Yield
- GLRE N/A
- ANGO N/A
- EPS Growth
- GLRE N/A
- ANGO N/A
- EPS
- GLRE 1.32
- ANGO N/A
- Revenue
- GLRE $717,617,000.00
- ANGO $283,320,000.00
- Revenue This Year
- GLRE N/A
- ANGO N/A
- Revenue Next Year
- GLRE N/A
- ANGO $6.35
- P/E Ratio
- GLRE $10.91
- ANGO N/A
- Revenue Growth
- GLRE 2.79
- ANGO N/A
- 52 Week Low
- GLRE $11.95
- ANGO $5.47
- 52 Week High
- GLRE $15.82
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- GLRE 46.81
- ANGO 37.31
- Support Level
- GLRE $14.06
- ANGO $9.33
- Resistance Level
- GLRE $14.56
- ANGO $10.24
- Average True Range (ATR)
- GLRE 0.30
- ANGO 0.40
- MACD
- GLRE -0.09
- ANGO -0.15
- Stochastic Oscillator
- GLRE 13.40
- ANGO 2.47
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.